EUVIMEDScopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC 4.0

Normothermic Regional Perfusion in Controlled Donation After Circulatory Death: Growing Evidence for Liver Transplantation

Daisuke Imai iD, Jacob Hallesy iD, Rohan Rathi, Christian Zbihley, Kush Savsani iD, Yuzuru Sambommatsu iD, Aamir A Khan iD, Vinay Kumaran iD, David A Bruno iD, Seung Duk Lee iD

Clinical Transplantation · 2026-02 · 40 (2)

DOI: 10.1111/ctr.70463 ↗

At a glance

Übersichtsarbeit in Clinical Transplantation, published online on 2026-01-30. Written by Daisuke Imai and 9 co-authors. Institution: Division of Transplant Surgery, Department of Surgery, Virginia Commonwealth University, Richmond, Virginia, USA. Major MEDLINE topics: Liver Transplantation, Perfusion, Organ Preservation, Tissue Donors. Cited 5 times so far (Crossref); 49 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Normothermic regional perfusion (NRP) has emerged as a pivotal strategy in controlled donation after circulatory death (cDCD) liver transplantation, mitigating ischemia‐reperfusion injury and improving graft outcomes. Compared to super rapid recovery (SRR), NRP significantly reduces rates of early allograft dysfunction, primary nonfunction, and biliary non‐anastomotic stricture (NAS), with biliary complications reported in 5%–16% and NAS as low as 0%–2%. Outcomes from cDCD‐NRP grafts are increasingly comparable to those of donation after brain death (DBD). Viability assessment during NRP remains variably defined across centers. Nonetheless, stable pump flow, stable or declining lactate levels, controlled transaminase levels, and favorable macroscopic appearance are commonly used parameters. Histological thresholds may guide graft acceptance but are not universally applied. Sequential use of ex situ machine perfusion following NRP offers additional benefits in marginal or prolonged ischemia settings. NRP implementation has improved liver utilization rates from 34% to 63% in the United Kingdom and from 39% to 71% in the United States. This review highlights NRP as a transformative platform that reshapes viability standards, expanding transplant access, and supports sustained growth in liver transplantation.

Subjects

MeSH terms (MEDLINE)

Liver TransplantationPerfusionOrgan PreservationTissue DonorsTissue and Organ ProcurementHumansGraft SurvivalReperfusion Injury

Author keywords

biliary complicationscontrolled donation after cardiac death liver transplantationnormothermic regional perfusionpostoperative survivalreview

Authors and institutions

  • Division of Transplant Surgery, Department of Surgery, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Department of Surgery, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.

ORCID profiles: Daisuke Imai, Jacob Hallesy, Kush Savsani, Yuzuru Sambommatsu, Aamir A Khan, Vinay Kumaran, David A Bruno, Seung Duk Lee

Cite

APA

Imai, D., Hallesy, J., Rathi, R., Zbihley, C., Savsani, K., Sambommatsu, Y., Khan, A. A., Kumaran, V., Bruno, D. A., & Lee, S. D. (2026). Normothermic Regional Perfusion in Controlled Donation After Circulatory Death: Growing Evidence for Liver Transplantation. Clinical Transplantation, 40(2). https://doi.org/10.1111/ctr.70463

Vancouver

Imai D, Hallesy J, Rathi R, Zbihley C, Savsani K, Sambommatsu Y, et al. Normothermic Regional Perfusion in Controlled Donation After Circulatory Death: Growing Evidence for Liver Transplantation. Clinical Transplantation. 2026;40(2). doi:10.1111/ctr.70463

BibTeX
@article{Imai2026,
  author = {Imai, Daisuke and Hallesy, Jacob and Rathi, Rohan and Zbihley, Christian and Savsani, Kush and Sambommatsu, Yuzuru and Khan, Aamir A and Kumaran, Vinay and Bruno, David A and Lee, Seung Duk},
  title = {Normothermic Regional Perfusion in Controlled Donation After Circulatory Death: Growing Evidence for Liver Transplantation},
  journal = {Clinical Transplantation},
  year = {2026},
  volume = {40},
  number = {2},
  doi = {10.1111/ctr.70463}
}
Start for free →